The biochemical diagnosis of Wilson's disease depends on a reduced level of serum caeruloplasmin (less than 20 mg/dl) and an elevated hepatic copper concentration (greater than 250 ,ug/g dry tissue) (Sternlieb and Scheinberg, 1968) . A few patients possess normal serum concentrations of caeruloplasmin (Bearn, 1953; Scheinberg and Sternlieb, 1963) but the levels usually fall during the course of D-penicillamine therapy.
The physiological role of caeruloplasmin is thought to be that of a ferroxidase. However, it can oxidise a wide variety of substrates, and the ability to catalyse the oxidation of aryldiamines has been widely employed in colorimetric assays for caeruloplasmin. Recently, due to the availability of commercial reagents, the measurement of caeruloplasmin immunochemically has gained acceptance on the assumption that immunoreactive caeruloplasmin is closely correlated with serum copper oxidase activity. While this may be true of most groups of subjects, in this study we report four patients with Wilson 
Methods
Copper oxidase activity was determined by a method modified from that of Curzon and Vallet (1960) . Serum (100 ,ul) was incubated at 37°C in 5-1 ml 0 43 mol/l sodium acetate buffer, pH 5 5, containing 20 mmol/l N,N-dimethyl-p-phenylenediamine sulphate and the increase in absorbance was recorded at one-minute intervals. The reaction rate was calculated from the average over 10 minutes while the reaction was linear, after allowing for the initial lag period of 1-2 minutes. were comparable with those in normal subjects.
Dialysis of sera from individuals with low copper oxidase activity/mg caeruloplasmin for 24 hours against 0-15 mol/l NaCl had no significant effect on copper oxidase activity under the conditions of the assay. After addition of an equal volume of these sera to normal serum, the copper oxidase activity was equal to the average of the two activities within the limits ± 5%. These results indicate that there was no dialysable non-competitive inhibitor of copper oxidase activity present.
Discussion
These results suggest that the functional abnormality in caeruloplasmin observed in these families is an inherited variant, which is not attributable to the presence of a serum inhibitor of copper oxidase. The individuals with this reduction of the oxidase activity of caeruloplasmin were all female, in whom the serum caeruloplasmin ranged from 11 to 36 mg/dl, but in five of the six subjects the values were either normal or near-normal. In all cases, including the two heterozygote mothers, the level of copper oxidase activity was abnormally low and consistent with that found in patients with Wilson's disease. Heterozygous carriers of Wilson's disease remain free of the disease for life, even though about 20% exhibit a low serum caeruloplasmin (Bickel et al., 1957; Sternlieb et al., 1961) ; in some series, however, Reduced oxidase activity in the caeruloplasmin of two families with Wilson's disease caeruloplasmin has been estimated by the copper oxidase method and hence, on the basis of these observations, individuals may have been included in whom there were normal levels of caeruloplasmin despite the reduced oxidase activity.
Since the observation that the serum caeruloplasmin is usually low in Wilson's disease (Bearn and Kunkel, 1952; Scheinberg and Gitlin, 1952) , distinct molecular species have been demonstrated which differ in chromatographic and electrophoretic behaviour (Curzon and Vallet, 1960; Broman, 1964) . Morell and Scheinberg (1960) 
